Medical Director, Nephrology and Dialysis Unit, IRCCS G. Gaslini – Genoa

Participation in nephrology laboratory research (nephropathy models, in situ hybridization, mesothelial cell studies)
 

Collaboration in:
o Immunopathogenesis of kidney diseases
o Alport syndrome research (national and European studies)
o Pediatric renal biopsy registry (1994–1997)
o Levamisole in nephrotic syndrome treatment
o Studies on dialysis adequacy and peritoneal dialysis
o Genetic reference for hemolytic uremic syndrome
o Reference physician for rare diseases department (2007–2009)
 

Clinical Trials (GCP-compliant):
o ESCAPE TRIAL – Co-investigator (2005–2010)
o CINCH – Study coordinator (2006–2008)
o Valsartan study – Principal Investigator (2007–2009)
o ESCAPE II – Principal Investigator (since 2008)
o HIP Atacand – Principal Investigator (2008–2009)
o C4 PODONET – Co-investigator (since 2009)
o Eculizumab study – Principal Investigator (2009–2012)
o Cardiovascular comorbidity in pediatric CKD – Principal Investigator (since 2011)
o Kidney transplant therapy study – Principal Investigator (since 2012)
o Kidney transplant outpatient care – Day hospital/ambulatory (since 2012)
o Consultant for BMT, hematology, oncology departments (since 2012)
o Acute kidney injury management and continuous dialysis (since 2009)
o Innovative therapies for transplant complications (since 2015)